SCHEMBL4549305

SCHEMBL4549305

CCCCc1ccc2sc3c(-c4ccc(-c5cc6ccccc6c6ccccc56)cc4)cc(CCCC)cc3c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 1/20 0.43
PTPN1 P18031 1/20 0.36
DHODH Q02127 1/20 0.35
CTSV O60911 2/20 0.35
CTSL P07711 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
RORA P35398 1/20 0.34
RORC P51449 1/20 0.34
RORB Q92753 1/20 0.34
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CNR2 P34972 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD11B1 P28845 1/20 0.32
AGTR1 P30556 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4549304 0.93 PSMB5 (0.34) PSMB5CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL16541612 0.86 PSMB5 (0.34) PSMB5PTPN1DHODHCTSVCTSL
SCHEMBL4549297 0.86 PIM1 (0.38) CYP1A2RORARORCRORBMAPT
SCHEMBL4549352 0.83 ALOX5 (0.45) PSMB5PTPN1DHODHCTSVCTSL
SCHEMBL4549310 0.81 DHODH (0.34) DHODHMAPTATML3MBTL1CNR2
SCHEMBL16541615 0.79
SCHEMBL8281205 0.79 PSMB5 (0.43) PSMB5DHODHMAPTALDH1A1SMN1; SMN2
SCHEMBL10127926 0.79 HSD11B1 (0.39) PSMB5DHODHATML3MBTL1HSD11B1
SCHEMBL9603910 0.78 NPC1 (0.45) PSMB5PTPN1MAPTATMALDH1A1
SCHEMBL10127367 0.77 POLB (0.40) PSMB5RORARORCRORBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9406889-B2 Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-02 US disclosed
US-20150171333-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-06-18 US disclosed
US-8968888-B2 Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-03-03 US disclosed
US-20120104369-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120104369-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device MC1R, NR2E3, RPS19 PSMB5 2805/4885PTPN1 3995/4885DHODH 3170/4885
US-20150171333-A1 Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device MC1R, NR2E3, RPS19 PSMB5 2805/4885PTPN1 3995/4885DHODH 3170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.